Reseda Lifesciences Private Limited

Reseda Lifesciences Private Limited - life sciences in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U73200KA2017PTC105451 Incorporated 09 August 2017 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company life sciences MSME · Micro
Data last updated
Revenue · FY 2025
₹47.04 Lakh
▼ 86% YoY
Net profit · FY 2025
₹14.06 Lakh
Net margin 29.9%
EBITDA · FY 2025
₹21.69 Lakh
EBITDA margin 46.1%
Authorised capital
₹65 Lakh
Registered with MCA
Paid-up capital
₹27.29 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹80 Lakh
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings

About Reseda Lifesciences Private Limited

Data last updated:

Reseda Lifesciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 09 August 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2017PTC105451. Its GSTIN is 29AAFCN7374L1ZQ (Karnataka).

The company has an authorised share capital of ₹65 Lakh and a paid-up capital of ₹27.29 Lakh. It was formerly known as Nettare Bio Labs Private Limited. It is led by directors Pamidipati Hela Gayatri (Managing Director) and Saligrama Kote Pradeep Kumar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2025, the company reported a revenue of ₹47.04 Lakh, a decline of 86% compared to the previous year. For the same year it recorded a net profit of ₹14.06 Lakh (net margin 29.9%) and EBITDA of ₹21.69 Lakh (EBITDA margin 46.1%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years and 26% over five years.

The company is associated with 1 brand: Reseda. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹80 Lakh on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 1 case is pending.

Reseda Lifesciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0046157). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website resedalife.com.

Company details

CIN U73200KA2017PTC105451
Registration Number 105451
Incorporation Date 09 August 2017
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0046157

Recognitions & Rankings of Reseda Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-KR-03-0046157

Contact details

Reseda Lifesciences Private Limited's registered office is in Bangalore, Karnataka. Its website is resedalife.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    28 First Floor 16th Main 38th Cross, Jayanagar 4th T Block, Bangalore, Karnataka, India – 560041
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Reseda Lifesciences Private Limited, buy the company report.

Comprehensive company report
Reseda Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Reseda Lifesciences operates one associated brand: Reseda. Each brand links to its own profile.

BrandDescriptionWebsite
Plant-based medicines are developed and manufactured via R&D efforts.resedalife.com

Business activity

The main business activities of Reseda Lifesciences are professional, scientific and technical and manufacturing. In detail, this covers scientific research and development and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Reseda Lifesciences Private Limited, buy the company report.

Financials of Reseda Lifesciences Private Limited

FY 2024 filings available

Reseda Lifesciences Private Limited reported revenue of ₹47.04 Lakh (down 86% YoY) for FY 2025.

Revenue · FY 2025
₹47.04 Lakh ▼ 86%
Net profit · FY 2025
₹14.06 Lakh margin 29.9%
EBITDA · FY 2025
₹21.69 Lakh margin 46.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 86%
3 years · compounded
▼ 38%
5 years · compounded
▼ 26%
EBITDA CAGR growth
1 year
▼ 72%
3 years · compounded
▲ 31%
5 years · compounded
▼ 4%

Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 86% fall in the latest year. EBITDA fell 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹21.69 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹14.06 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin46.1%
Net Profit Margin29.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Reseda Lifesciences Private Limited, buy the company report.

Board of directors of Reseda Lifesciences Private Limited

Reseda Lifesciences has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Saligrama Kote Pradeep KumarDirector06 Mar 20197 Years 7 MonthsCurrent
Pamidipati Hela GayatriManaging Director09 Aug 20179 Years 2 MonthsCurrent

Auditor

Reseda Lifesciences Private Limited is audited by GARG AND ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
GARG AND ASSOCIATESFY 2023000185C

Shareholding

The shareholding of Reseda Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Reseda Lifesciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
₹80 Lakh
Breakdown by lending institutions
Axis Bank Limited₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Dec 2021100521099Axis Bank Limited₹50 LakhOpen
29 Oct 2020100385016Axis Bank Limited₹80 LakhSatisfied

To see the full charge records of Reseda Lifesciences Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Reseda Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Reseda Lifesciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAFCN7374L1ZQKarnatakaActive01 Sep 2017

To see the full GST registrations and return filing status of Reseda Lifesciences Private Limited, buy the company report.

Recent activity

Reseda Lifesciences Private Limited has 10 board changes on record since 2017: 2 appointments and 8 cessations. The latest: Christopher John Perry ceased to be Director on 18 Jul 2022.

AGM
Reseda Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 29 Oct 2020 via Charge ID 100385016 with Axis Bank Limited was fully satisfied on 21 Sep 2024.
Filing
Reseda Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Ceased
Christopher John Perry ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100521099 was registered on 24 Dec 2021.
Charges
A charge with Axis Bank Limited of Rs. 80.00 Lakh registered on 29 Oct 2020 with Charge ID 100385016 was modified on 05 Nov 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 80.00 Lakh with Charge ID 100385016 was registered on 29 Oct 2020.
Ceased
Lalitha Sri Pamidipati ceased to be Additional Director.
Ceased
Saligrama Kote Pradeep Kumar ceased to be Additional Director.
Ceased
Pamidipati Hela Gayatri ceased to be Director.
Appointed
Saligrama Kote Pradeep Kumar was appointed as Director.
Ceased
Praveen Paul ceased to be Director.

5 earlier events are in the company report.

Frequently asked questions

Reseda Lifesciences is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 09 August 2017 (9+ years old) and is registered under CIN U73200KA2017PTC105451.

Reseda Lifesciences has 2 current directors:

The latest financial statements of Reseda Lifesciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Reseda Lifesciences is 29AAFCN7374L1ZQ, registered in Karnataka.

The CIN (Corporate Identification Number) of Reseda Lifesciences is U73200KA2017PTC105451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Reseda Lifesciences has 6 court cases on record: 1 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.

Reseda Lifesciences was incorporated on 09 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.

Christopher John Perry ceased to be Director on 18 Jul 2022. Lalitha Sri Pamidipati ceased to be Additional Director on 30 Sep 2019. Saligrama Kote Pradeep Kumar ceased to be Additional Director on 30 Sep 2019. Reseda Lifesciences has 10 board changes on record in total.

Yes, Reseda Lifesciences is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0046157).

Reseda Lifesciences can be reached through the website resedalife.com. Its registered office is in Bangalore, Karnataka, India.